5 Developing Storylines in the Orthopedic Market for 2022
The orthopedic market is navigating a time of significant change as slow-developing trends start reaching critical mass. Jun 23, 2022
COVID Abatement in First Quarter Brings Relief for Most Pressured Segments
Knee replacement, hip replacement and spine have been the most susceptible to disruption from procedure cancelations during the pandemic. Jun 15, 2022
Orthopedic Sales Off to Faster Than Expected Start in 2022
We estimate orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges are manageable. Jun 02, 2022
Medtronic Marks One Year of Transformation
The company's renewed focus on competitiveness and market share paid off in its fiscal year 2022, as Medtronic grew in the mid-single digits. May 31, 2022
SI-BONE Hits Procedure Volume Record in March
The company grew in the high single digits for 1Q22, driven by a company record for procedure volume in March. May 20, 2022
OrthoPediatrics’ Growing Surgeon Adoption Offsets Headwinds
The company grew in the high single digits for 1Q22 as its non-elective trauma business offset COVID-related elective procedure headwinds. May 19, 2022
Surgalign Looks to Extend Runway for HOLO Platform
The company declined in the double digits for 1Q22 as it continues the early commercialization efforts of its HOLO platform. May 19, 2022
Bioventus Focused on Double-Digit Growth and Debt Reduction
The company's orthopedic sales grew 9% organically in 1Q22 as Bioventus targets double-digit organic growth for the full year. May 17, 2022
Treace Benefits from Commercial Investments
The company grew more than 55% in 1Q22 on the strength of its narrow procedure focus and expanding direct sales force. May 17, 2022
Vericel Reaffirms MACI Guidance for 2022
The company grew in the high single-digits during a better than expected 1Q22 and restated its full-year guidance for MACI. May 16, 2022
